Home > ASME Articles > The Prescription Opioid Treatment Study: What Have We Learned?
In addition to main trial results, the study yielded numerous secondary analyses, and included a 3.5-year follow-up study (CTN-0030-A-3), the first of its kind with this population.
This paper summarizes the POATS design, main outcomes, predictors of outcome, subgroup analyses, the predictive power of early treatment response, and the long-term follow-up study.
POATS examined combinations of buprenorphine-naloxone of varying duration and counseling of varying intensity.
The study had several key results:
In particular, the results of POATS suggest support for an individualized approach to behavioral interventions in the context of buprenorphine-naloxone treatment of prescription opioid use disorders. The fact that some patients benefited from counseling (heroin users who attended sessions regularly, for example) suggests that some patients would do well with just medical management and others should receive additional counseling.